Multicenter Phase II Study of Whole-Body and Intracranial Activity with Ceritinib in Patients with ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated with Chemotherapy and Crizotinib : Results from ASCEND-2
J Clin Oncol. 2016 Aug 20;34(24):2866-2873.
Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC : An Adjusted Comparison with External Controls
J Thorac Oncol. 2016;11(9):1550-1557.